PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Vistagen to continue social anxiety nasal spray trials

Vistagen Therapeutics announced this week that it will proceed with its Phase 3 clinical trial assessing drug candidate PH94B for adults with Social Anxiet...
Continue Reading →
News

Imara offloads sickle cell drug to Cardurion

Imara will be selling its sickle cell disease candidate and all other assets related to its PDE9 program to startup Cardurion Pharmaceuticals, as the strug...
Continue Reading →
News

Stada launches prostate cancer treatment across 21 European countries

The company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer. Stada is broadening its offering to patients, pharmacists and ...
Continue Reading →
News

Brand new state-of-the-art Nemera offices inaugurated in Lyon

Located in the bio district of Gerland, the BREEAM-certified collaborative space will house Nemera’s headquarters & European innovation teams. Mornin...
Continue Reading →
News

Positive phase 3 data for Sanofi’s Dupixent

Research showed significant improvements in signs and symptoms of prurigo nodularis. It has been revealed that, during a trial, nearly three times as many Dupixen...
Continue Reading →
News

Valneva and VBI announce partnership for hepatitis B vaccine

Collaboration involves the marketing and distribution of PreHevbri across Europe. Valneva and VBI Vaccines have announced a partnership in select European markets...
Continue Reading →
News

BioInnovation Institute reveals new cohort entering Venture Lab programme

Group consists of nine ventures plus corporate-sponsored innovation projects from Novo Nordisk. BioInnovation Institute (BII) – the international commercial non-p...
Continue Reading →
News

First patient enrolled in Modus’ sevuparin trial

Research is evaluating the therapy among paediatric patients with severe malaria. Modus Therapeutics (Modus) – a company developing treatments for patients with h...
Continue Reading →
News

Green light for cancer drugs developed by AI specialist Owkin

AI company has its breast cancer and colorectal therapies approved for use in Europe. AI biotech company Owkin has announced that two first-in-class rapid, afford...
Continue Reading →
News

Avacta announces clinical study of AVA6000

Pro-doxorubicin will advance to the fourth dose following a positive review of safety and tolerability. Avacta Group – which develops oncology drugs based on its ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026